@article{dae57cd50053451182a54db880525b41,
title = "ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males",
abstract = "The new ISA, ISSAM, EAU, EAA and ASA recommendations on the investigation, treatment and monitoring of late-onset hypogonadism in males provide updated evidence-based information for clinicians who diagnose and treat patients with adult onset, age related testosterone deficiency.",
keywords = "Late onset hypogonadism, Testosterone deficiency, Testosterone treatment",
author = "C. Wang and E. Nieschlag and R. Swerdloff and Behre, {H. M.} and Hellstrom, {W. J.} and Gooren, {L. J.} and Kaufman, {J. M.} and Legros, {J. J.} and B. Lunenfeld and A. Morales and Morley, {J. E.} and C. Schulman and Thompson, {I. M.} and W. Weidner and Wu, {F. C.W.}",
note = "Funding Information: The following authors have disclosed their financial support and/or association with organizations that may have a direct financial interest in the material contained in the paper. C Wang has served as a temporary consultant for Indevus, and has received research support from Acrux, Indevus, M et P, Clarus Therapeutics and Besins Healthcare. E Nieschlag and H Behre has received honoraria from various sources for lectures on testosterone, JJ Legros has received a lecture fee from Organon. A Morales has received research support from Solvay. JE Morley has served as a consultant for Solvay and has stock ownership in Mattern Pharmaceuticals. RS Swerdloff has disclosed their financial support as grant recipient, consultant or sponsored speaker in the following companies: Acrux (Consultant, Grant Recipient); Ardana (Consultant, Grant Recipient); Auxillium (Consultant, Grant Recipient, Speaker); Clarus (Consultant, Grant Recipient); Glaxo SmithKline (Consultant, Grant Recipient); Indevus (Consultant, Grant Recipient); Organon (Grant recipient); Pierre Fabre (Consultant); Solvay Pharmaceuticals, Inc Company (Consultant, Grant Recipient, Speaker) and Repros (Consultant, Grant Recipient). RS Swerdloff is not a stockholder or owner of any of these companies. The following authors: W Hellstrom, L Gooren, J Kaufman, B Lunenfeld, C Schulman, IM Thompson, W Weidner and FCW Wu have certified that they have no financial disclosures to make regarding their participation in the data analysis, writing and approval of this paper.",
year = "2009",
month = jan,
doi = "10.1038/ijir.2008.41",
language = "English (US)",
volume = "21",
pages = "1--8",
journal = "International Journal of Impotence Research",
issn = "0955-9930",
publisher = "Nature Publishing Group",
number = "1",
}